← Back
$DYN All transactions

Dyne Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$107K

Shares

5,727

Price

$19

Filed

Apr 3

Insider

Name

Lucera Erick

Title

Chief Financial Officer

CIK

0001697616

Roles

Officer

Transaction Details

Transaction Date

2026-04-01

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

125,373

Footnotes

Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on March 31, 2025. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $18.24 to $18.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4. | Includes 114,575 unvested RSUs.

Filing Info

Accession No.

0001193125-26-142137

Form Type

4

Issuer CIK

0001818794

Lucera Erick's History

Date Ticker Type Value
2026-04-01 DYN $107K
2025-12-16 SABS A $0
2025-11-04 XAIR D
2025-11-04 XAIR A
2025-11-04 XAIR D
2025-11-04 XAIR A
2025-11-04 XAIR D
2025-11-04 XAIR A
2025-11-04 XAIR D
2025-11-04 XAIR A

Other Insiders at DYN (90d)

Insider Bought Sold Last
Posner Brian S $34K 2026-03-30
Rhodes Jason P $16.5M 2026-04-22
Kersten Dirk $9.1M 2026-04-22